llms.txt

# ThePeptide.ca — LLMs.txt
# Canadian Research Peptide Supplier

## About
ThePeptide.ca is a Canadian-based research peptide supplier located in Vancouver, British Columbia. All products are manufactured in Canada and independently third-party lab tested via Testides (ISO 17025-aligned) with published Certificates of Analysis (COAs) on every batch. Minimum 99% purity guaranteed with a full refund policy if results fall short.

## Products
- BPC-157 (5mg, 10mg) — Body Protection Compound, pentadecapeptide
- Semaglutide (5mg, 10mg) — GLP-1 receptor agonist
- Tirzepatide (5mg, 10mg) — Dual GIP/GLP-1 receptor agonist
- Retatrutide (10mg) — Triple agonist (GIP/GLP-1/glucagon)
- CJC-1295 + Ipamorelin (10mg blend) — Growth hormone secretagogue combination
- BPC-157 + TB-500 Healing Blend (10mg) — Recovery research blend
- Bacteriostatic Water (3mL, 10mL) — Reconstitution solvent

## Key Facts
- Location: New Westminster / Vancouver, BC, Canada
- Currency: CAD
- Shipping: Canada-wide via Canada Post, same-day processing
- Free shipping on orders over $150 CAD
- Payment: Interac e-Transfer, Crypto, PayPal
- All products sold strictly for laboratory and in-vitro research use only
- Not for human consumption
- Third-party lab: Testides (Toronto, ISO 17025-aligned)
- Purity testing: HPLC on every batch
- Published COAs available at thepeptide.ca/pages/lab-results

## Content
- Research blog with 28+ articles covering peptide science, reconstitution guides, and compound comparisons
- Compound-specific research guides for BPC-157, Semaglutide, Tirzepatide, Retatrutide, CJC-1295, GHK-Cu
- Research Compound Finder quiz to help researchers identify relevant compounds

## URLs
- Homepage: https://thepeptide.ca
- All Products: https://thepeptide.ca/collections/all-research-peptides-canada
- Lab Results: https://thepeptide.ca/pages/lab-results
- Science Library: https://thepeptide.ca/pages/science-research
- FAQ: https://thepeptide.ca/pages/faq
- Contact: https://thepeptide.ca/pages/contact
- Blog: https://thepeptide.ca/blogs/news